A. AKAY Et Al. , "Atomoxetine treatment may decrease striatal dopaminergic transporter availability after 8 weeks: pilot SPECT report of three cases," NEUROPSYCHIATRIC DISEASE AND TREATMENT , vol.11, pp.2909-2911, 2015
AKAY, A. Et Al. 2015. Atomoxetine treatment may decrease striatal dopaminergic transporter availability after 8 weeks: pilot SPECT report of three cases. NEUROPSYCHIATRIC DISEASE AND TREATMENT , vol.11 , 2909-2911.
AKAY, A., ÇAPA KAYA, G., BAYKARA, H. B., Demir, Y., Oezek, H., ALŞEN GÜNEY, S., ... Eren, M. S.(2015). Atomoxetine treatment may decrease striatal dopaminergic transporter availability after 8 weeks: pilot SPECT report of three cases. NEUROPSYCHIATRIC DISEASE AND TREATMENT , vol.11, 2909-2911.
AKAY, AYNUR Et Al. "Atomoxetine treatment may decrease striatal dopaminergic transporter availability after 8 weeks: pilot SPECT report of three cases," NEUROPSYCHIATRIC DISEASE AND TREATMENT , vol.11, 2909-2911, 2015
AKAY, AYNUR Et Al. "Atomoxetine treatment may decrease striatal dopaminergic transporter availability after 8 weeks: pilot SPECT report of three cases." NEUROPSYCHIATRIC DISEASE AND TREATMENT , vol.11, pp.2909-2911, 2015
AKAY, A. Et Al. (2015) . "Atomoxetine treatment may decrease striatal dopaminergic transporter availability after 8 weeks: pilot SPECT report of three cases." NEUROPSYCHIATRIC DISEASE AND TREATMENT , vol.11, pp.2909-2911.
@article{article, author={AYNUR AKAY Et Al. }, title={Atomoxetine treatment may decrease striatal dopaminergic transporter availability after 8 weeks: pilot SPECT report of three cases}, journal={NEUROPSYCHIATRIC DISEASE AND TREATMENT}, year=2015, pages={2909-2911} }